Histopathology,
Journal Year:
2024,
Volume and Issue:
85(4), P. 566 - 578
Published: May 24, 2024
Aims
Porocarcinoma
is
a
malignant
sweat
gland
tumour
differentiated
toward
the
upper
part
of
duct
and
may
arise
from
transformation
preexisting
benign
poroma.
In
2019,
Sekine
et
al.
demonstrated
presence
YAP1::MAML2
YAP1::NUTM1
fusions
in
most
poromas
porocarcinomas.
Recently,
our
group
identified
PAK2‐
subset
poromas.
Herein
we
report
series
12
porocarcinoma
cases
harbouring
PAK1/2/3
fusions.
Methods
Results
Five
patients
were
male
median
age
was
79
years
(ranges:
59–95).
Tumours
located
on
trunk
(
n
=
7),
thigh
3),
neck
1),
or
groin
area
1).
Four
developed
distant
metastases.
Microscopically,
seven
harboured
poroma
component
invasive
part.
Ductal
formations
observed
all,
while
infundibular/horn
cysts
cells
with
vacuolated
cytoplasm
detected
six
tumours,
respectively.
three
cases,
consisted
proliferation
elongated
cells,
some
which
formed
pseudovascular
spaces,
whereas
others
predominant
solid
trabecular
growth
pattern.
Immunohistochemical
staining
for
CEA
EMA
confirmed
ducts.
Focal
androgen
receptor
expression
specimens.
Whole
RNA
sequencing
evidenced
LAMTOR1::PAK1
2),
ZDHHC5::PAK1
DLG1::PAK2
,
CTDSP1::PAK1
CTNND1::PAK1
SSR1::PAK3
CTNNA1::PAK2
RNF13::PAK2
ROBO1::PAK2,
CD47::PAK2
.
Activating
mutation
HRAS
(G13V,
3,
G13R,
1,
Q61L,
2)
present
cases.
Conclusion
Our
study
suggests
that
oncogenic
driver
porocarcinomas
lacking
YAP1
rearrangement.
American Journal of Dermatopathology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 6, 2025
Abstract:
Gene
rearrangements
or
fusions
have
emerged
as
critical
oncogenic
drivers
in
various
cutaneous
adnexal
neoplasms.
This
review
offers
a
comprehensive
overview
of
both
established
and
recently
identified
molecular
alterations,
with
specific
focus
on
gene
fusions.
Key
alterations
discussed
include
YAP1
rearrangements,
CRTC1::MAML2
fusions,
BRD3
MYB::NFIB
ETV6::NTRK3
PLAG1
alongside
rarer
fusion
transcripts,
such
MEF2C::SS18
,
FOXK1::GRHL1/2
GPS2::GRHL
RARA::NPEPPS
.
The
article
highlights
the
significance
these
genetic
changes
tumor
biology
their
potential
therapeutic
implications
for
locally
advanced
metastatic
skin
tumors.
It
also
addresses
diagnostic
challenges
distinctions,
providing
updated
insights
into
tumors
driven
by
Histopathology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 24, 2025
NUT
carcinoma
is
a
rare
malignant
neoplasm
characterised
by
recurrent
NUTM1
rearrangements,
initially
reported
in
the
midline.
Recently,
10
cases
of
cutaneous
with
adnexal
differentiation
harbouring
BRD3::NUTM1,
NSD3::NUTM1,
BRD4::NUTM1
or
BRD3::NUTM2B
fusions
have
been
reported.
Accordingly,
'NUT
carcinoma'
(NAC)
has
introduced
as
provisional
tumour
entity
to
fifth
edition
WHO
Classification
Skin
Tumours.
We
report
histopathological,
molecular
genetic
and
epigenetic
features
seven
additional
NAC.
The
cohort
consisted
four
female
three
male
patients
median
age
58
years.
Follow-up
was
available
for
six
cases,
documented
diffuse
metastatic
spreading
leading
death
at
18
months
after
diagnosis
one
case.
Histopathological
examination
all
revealed
dermal/subcutaneous
neoplasms
composed
poorly
differentiated
cells
large
irregular
vesicular
nuclei
least
focally
prominent
nucleoli.
All
showed
areas
duct/gland
formation.
Using
immunohistochemistry,
tumours
expression
co-expression
SOX10
five
cases.
P63
P40
were
diffusely
positive
case
confined
periphery
nests
Molecular
analysis
(n
=
3),
BRD3::NUTM1
3)
NSD3::NUTM1
1).
Although
being
close
this
latter
group,
methylation
transcriptional
that
NAC
formed
unique
cluster
distinct
from
extracutaneous
NUTM1-rearranged
porocarcinoma.
Our
results
further
support
existence
primary
suggest
it
may
represent
an
carcinoma.
International Journal of Gynecological Pathology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: May 8, 2025
Microcystic
adnexal
carcinoma
(MAC)
and
eccrine
cutaneous
mixed
tumor
(ECMT)
are
both
tumors
that
may
occur
in
the
vulvar
region,
but
very
rare
at
this
site.
Consequently,
they
not
enter
differential
diagnosis
of
lesions
for
gynecologic
pathologists
a
subspecialized
practice
setting.
Here
we
report
case
MAC
ECMT
recently
diagnosed
our
institution
underscore
key
histologic
immunophenotypic
features
each
lesion
can
assist
their
correct
identification.
Both
have
tubular
to
corded
pattern
lesional
cells
within
desmoplastic
chondromyxoid
stroma.
However,
shows
true
sweat
duct
differentiation,
characterized
by
2
SOX10
negative
cell
layers,
including
an
outer
p63+/p40+/EMA−
basal
layer
inner
p63−/p40−/EMA+
ductal
layer.
The
main
diagnostic
considerations
include
other
with
namely
syringoma
squamoid
(SEDC).
Conversely,
is
single
SOX10+
population
without
immunoreactivity
p63
or
p40.
apocrine
variant
(ACMT)—the
analog
salivary
gland
pleomorphic
adenoma—and
gland-type
neoplasms.
Unlike
described
HPV-associated
multiphenotypic
sinonasal
carcinoma,
neither
nor
therefore
p16
negative.
In
summary,
one
discuss
ancillary
testing
results
help
differentiate
these
from
morphologic
mimics.
The American Journal of Surgical Pathology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 8, 2024
Oncocytic
adenocarcinoma
(OC)
of
the
salivary
glands
is
a
rare
and
controversial
entity.
It
was
recently
reclassified
as
"salivary
carcinoma
NOS
emerging
entities"
in
2022
WHO
classification
head
neck
tumors.
The
lack
specific
molecular
alterations
its
potential
affiliation
with
other
gland
carcinomas,
such
oncocytic
mucoepidermoid
carcinomas
(OMEC)
or
subtype
duct
(OSDC)
justified
this
reclassification.
becoming
essential
to
clarify
complex
spectrum
diagnoses
surrounding
objective
study
explore
histologic
features,
well
immunohistochemical
profiles,
cases
previously
diagnosed
OC
OMEC
glands.
This
involved
28
predominantly
component.
sex
distribution
equal.
median
age
59
years
(range
10
89).
Most
these
originated
from
parotid
(25/28).
mean
tumor
size
2.4
cm
0.5
6.5).
Primary
immuno-morphological
mutation/gene
fusion
profiles
mainly
(64.3%,
18/28).
them
were
descending
order
OSDC
(8/18),
(5/18),
(2/18).
But
3
remained
unclassified
(3/18).
transcriptomic
analysis
found
proximity
their
profile
group
distance
OSDCs.
These
findings
imply
that
not
distinct
but
represents
variants
carcinomas.
underscores
importance
thorough
morphologic,
immunohistochemical,
examinations
accurately
diagnose
predominant
components
Genes Chromosomes and Cancer,
Journal Year:
2024,
Volume and Issue:
63(6)
Published: June 1, 2024
ABSTRACT
The
widespread
use
of
advanced
molecular
techniques
has
led
to
the
identification
several
tumor
types
with
PLAG1
gene
fusions
some
which
also
affect
skin
and
soft
tissues.
Herein,
we
present
a
38‐year‐old
female
subcutaneous
affecting
her
forearm,
does
not
seem
fit
into
any
currently
recognized
entity.
It
was
well‐circumscribed
measuring
6
×
4,5
4
cm.
had
thick
capsule
composed
bland
spindle
cells
forming
palisades
Verocay
body‐like
structures
within
myxocollagenous
background.
Scattered
calcifications
were
dispersed
throughout
lesion.
No
cytological
atypia,
mitotic
activity,
or
necrosis
present.
Targeted
NGS
revealed
SOX10::PLAG1
fusion
fluorescent
in
situ
hybridization
confirmed
presence
rearrangement.
neoplastic
showed
diffuse
immunohistochemical
expression
S100,
SOX10,
PLAG1,
as
well
patchy
desmin
CD34
positivity.
methylation
profile
this
did
match
other
entity
covered
by
DKFZ
sarcoma
classifier
apart
from
gain
chromosome
12,
copy
number
normal.
completely
excised,
patient
been
free
disease
for
years
since
excision.
While
more
cases
are
needed
confirm
distinct
entity,
propose
provisional
name
“
‐rearranged
calcifying
cell
tumor.”